The 20 Best Methicillin-Resistant Staphylococcus Aureus (MRSA) Doctors Near Me in Bronx, NY

Vagish Hemmige is an Infectious Disease provider in Bronx, New York. Dr. Hemmige is rated as an Advanced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are HIV/AIDS, Strongyloidiasis, Rhabditida Infections, and Methicillin-Resistant Staphylococcus Aureus (MRSA).

Anne-catrin Uhlemann is an Internal Medicine provider in New York, New York. Dr. Uhlemann is rated as a Distinguished provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), COVID-19, Sepsis, and Malaria.

Dr Franklin Lowy is the Clyde '56 and Helen Wu professor of medicine and pathology & cell biology (in epidemiology) in the Division of Infectious Diseases in the College of Physicians and Surgeons at Columbia University. His laboratory investigates the pathogenesis and epidemiology of Staphylococcus aureus and Staphylococcus epidermidis infections. Dr. Lowy is rated as a Distinguished provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Sepsis, and Endocarditis.

Leadership: Dr. Nosanchuk is an internationally regarded leader in undergraduate medical education, serving most recently as the Senior Associate Dean for Medical Education at Einstein. From 2020-2023, he led a complete revision of the MD program curriculum that included launching new required longitudinal courses on service learning, scholarship, and health systems sciences, and transforming the training phases to a 17-month pre-clinical period followed by 12-months of clerkships and 18-months of individualized professional development. Dr. Nosanchuk has received various education and leadership awrds from Einstein and medical/scientific societies. Dr. Nosanchuk serves on various external education and society committees, including being a member of the Executive Board of the National Board of Medical Examiners. Dr. Nosanchuk is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Paracoccidioidomycosis, Cryptococcosis, Sporotrichosis, and Melioidosis.

Dr. Liise-anne Pirofski is a physician-scientist. Her research programs focus on host-microbe interaction and antibody immunity to infectious diseases. Dr. Pirofski is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Cryptococcosis, Severe Acute Respiratory Syndrome (SARS), COVID-19, and Meningitis.

Yoram A. Puius, MD, PhD, is an attending physician, Associate Professor, Medicine and Associate Professor, Cardiothoracic & Vascular Surgery at Montefiore Einstein. His clinical focus centers on treating infections in the immunocompromised host, including recipients of solid organ transplants, patients with hematologic malignancies and recipients of cellular therapy. Dr. Puius is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Pneumocystis Jiroveci Pneumonia, Cytomegalovirus Infection, Cytomegalic Inclusion Disease, and Malaria.

Julio Ramirez is a primary care provider, practicing in Internal Medicine in Bronx, New York. Dr. Ramirez is rated as a Distinguished provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Pneumonia, Hospital-Acquired Pneumonia, Methicillin-Resistant Staphylococcus Aureus (MRSA), and Flu.

Dr. Rachel Bartash received her undergraduate degree from Duke University and her medical degree from the Albert Einstein College of Medicine. She completed her Internal Medicine residency training at the University of Michigan. Following completion of her residency, she was an Instructor in the Department of General Medicine at the University of Michigan and the VA Ann Arbor Healthcare system. She returned to NY in 2015 when she began her fellowship training in Infectious Diseases at Montefiore Medical Center. During her fellowship, Dr. Bartash was an integral part of the antimicrobial stewardship program and her research focused the use of MRSA screening as a tool for de-escalation of antibiotics. Dr. Bartash is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Febrile Neutropenia, Cytomegalic Inclusion Disease, Cytomegalovirus Infection, and Toxocariasis.

Brenda I. Anosike, MD, MPH, is Director, Pediatric Antimicrobial Stewardship at Children’s Hospital at Montefiore and Assistant Professor, Pediatrics at Montefiore-Einstein. Dr. Anosike’s clinical focus is on the treatment of various infectious diseases in healthy children, adolescents and young adults as well as those with complex medical conditions and the immunocompromised. She is co-lead for the pediatric COVID-19 monoclonal antibody program, antimicrobial/diagnostic stewardship program and global health. Dr. Anosike is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Orbital Cellulitis, Periorbital Cellulitis, H Influenzae Meningitis, and COVID-19.

My research interests are: Clostridium difficile, Tuberculosis, Molecular epidemiology, Molecular mechanisms of antibiotic resistance, Bacteriophage Therapy. Dr. Riska is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Marilou Corpuz is an Infectious Disease provider in New York, New York. Dr. Corpuz is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Sepsis, Osteomyelitis, Chronic Recurrent Multifocal Osteomyelitis, and Osteomyelitis in Children.

Ammara Mushtaq is an Infectious Disease provider in Bronx, New York. Dr. Mushtaq is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Sepsis, Lemierre Syndrome, Nocardiosis, and Pneumonia.

Mitchell Shear is a primary care provider, practicing in Internal Medicine in Bronx, New York. Dr. Shear is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Sepsis, Asthma in Children, Asthma, Gastrostomy, and Endoscopy.

Efrain Gonzalez is an Internal Medicine provider in Bronx, New York. Dr. Gonzalez is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Myelitis, AIDS Dysmorphic Syndrome, AIDS Dementia Complex, and HIV/AIDS.

Benjamin Miko is an Internal Medicine provider in New York, New York. Dr. Miko is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), HIV/AIDS, Myelitis, and AIDS Dementia Complex. Dr. Miko is currently accepting new patients.

Adam Zimilover is a primary care provider, practicing in Infectious Disease in Bronx, New York. Dr. Zimilover is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, Histiocytosis, and Reticulohistiocytoma.

Priya Nori is an Infectious Disease provider in Bronx, New York. Dr. Nori is rated as an Advanced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Osteomyelitis, Methicillin-Resistant Staphylococcus Aureus (MRSA), COVID-19, and Febrile Neutropenia.

Barry Baker is a primary care provider, practicing in Internal Medicine in Bronx, New York. Dr. Baker is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Hypertensive Heart Disease, Enlarged Liver, Pediatric Myocarditis, Gastrostomy, and Colonoscopy.

Marcus Pereira, MD, is an Associate Professor of Medicine at CUMC and the Director of Clinical Services in the Division of Infectious Diseases. In addition, he is the Medical Director of the Transplant Infectious Diseases Program, where he oversees the development of infection prophylaxis and treatment protocols for immunocompromised patients. His areas of interest include the management of multi-drug resistant bacterial and fungal infections, as well as drug resistant CMV infections and more recently the impact of COVID-19 in transplant recipients. He has also collaborated in important multi-center studies as well as the 2025 International CMV Guidelines, sponsored by the Transplantation Society. Dr. Pereira is an active member in national societies such as the American Society of Transplantation and Infectious Disease Society of America, and is an Associate Editor for the American Journal of Transplantation. Dr. Pereira is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Cytomegalovirus Infection, Cytomegalic Inclusion Disease, HIV/AIDS, and Spontaneous Bacterial Peritonitis.

Dr. Gomez-Simmonds’ research interests entail understanding the molecular factors that potentiate the acquisition and dissemination of multidrug resistance among hospital-associated pathogens. Her current projects focus on developing sequencing-based methods for investigating the epidemiology and transmission of multidrug-resistant Gram-negative bacteria at CUIMC such as carbapenem-resistant and ESBL-producing Enterobacterales. She is particularly interested in characterizing the repertoire of antibiotic resistance genes and associated mobile genetic elements in these pathogens. Additional research interests include identifying clinical risk factors and optimal therapeutic regimens for multidrug-resistant bacterial infections and investigating the clinical and microbiome factors associated with colonization and subsequent infection with hospital-associated pathogens such as Clostridioides difficile. Dr. Gomez is rated as an Experienced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Sepsis, HIV/AIDS, Methicillin-Resistant Staphylococcus Aureus (MRSA), and Myelitis.